1997 | Comparison of biological phenotypes according to midkine expression in gastric cancer cells and their autocrine activities could be modulated by pentosan polysulfate | CANCER LETTERS |
1997 | High Level of Urokinase-Type Plasminogen Activator Is a New Prognostic Marker in Patients with Gastric Carcinoma | CANCER |
1997 | Correlation between K-ras gene mutation and prognosis of patients with nonsmall cell lung carcinoma | CANCER |
1997 | Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression | BREAST CANCER RESEARCH AND TREATMENT |
1997 | P-glycoprotein: The intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
1997 | Retrospective Comparison of Infusional 5-Fluorouracil, Doxorubicin, and Mitomycin-C (Modified FAM) Combination Chemotherapy Versus Palliative Therapy in Treatment of Advanced Gastric Cancer | American Journal of Clinical Oncology |
1997 | 유방암 진행에 따른 Telomerase Activity 발현 증가
| Journal of the Korean Cancer Association (대한암학회지) |
1996 | 악성 종양 환자에서 새로운 Anthracycline 유도체: DA-125의 제1상 및 약동학 연구
| Journal of the Korean Cancer Association(대한암학회지) |
1996 | 골육종환자에서 다방면 복합요법의 효과 및 P-Glycoprotein 과다발현의 임상적 의의
| Journal of the Korean Cancer Association(대한암학회지) |
1996 | Sequential activation and production of matrix metalloproteinase-2 during breast cancer progression | CLINICAL & EXPERIMENTAL METASTASIS |
1996 | Overexpression of c-ErbB-2 Protein in Gastric Cancer by Immunohistochemical Stain | ONCOLOGY |
1996 | Sequential production and activation of matrix-metalloproteinase-9 (MMP-9) with breast cancer progression | BREAST CANCER RESEARCH AND TREATMENT |
1996 | 유방암에서 Matrix-metalloproteinase-9(MMP-9)의 발현
| Journal of the Korean Cancer Association(대한암학회지) |
1996 | Gastric Cancer in Young Patients Who Underwent Curative Resection: Comparative Study with Older Patients | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS |
1996 | 위암에서 침윤과 전이의 새로운 생물학적 표지자로서 urokinase-type plasminogen activator(uPA)의 발현
| Journal of the Korean Cancer Association(대한암학회지) |
1996 | 직장암에서 c-erbB-3의 발현과 예후인자로서 임상적 응용
| Journal of the Korean Cancer Association(대한암학회지) |
1996 | 위암에서 Collagen-4 및 Type-4 Collagenase의 발현과 예후인자로서 임상적 응용
| Korean Journal of Gastroenterology |
1996 | P-glycoprotein: The intermediate end point of drug response to induction chemotherapy in locally advanced breast cancer | BREAST CANCER RESEARCH AND TREATMENT |
1995 | 인체 위암조직에서 새로운 생물학적 치료목표로서 기저막 단백분해효소(Matrix-metalloproteinase-2,-9)의 발현
| Journal of the Korean Cancer Association(대한암학회지) |
1995 | 근치적 절제술이 시행된 대장 및 직장암에서 c-erbB-2의 표현과 임상적 의의
| Journal of the Korean Cancer Association(대한암학회지) |
1995 | 임파절 전이가 없는 유방암의 예후인자
| Journal of the Korean Cancer Association(대한암학회지) |
1995 | 위암환자의 종양지표지자로서 혈액내 c-erbB-2 종양단백의 탐색
| Journal of the Korean Cancer Association(대한암학회지) |
1995 | 진행위암환자에서 지속주입 5-Fluorouracil,Doxorubicin,Mitomycin-C(Modified FAM) 병용요법과 보조요법의 후향적 비교연구
| Journal of the Korean Cancer Association(대한암학회지) |
1995 | 위암에서의 증식세포 핵항원(PCNA) 발현이 예후에 미치는 영향
| Journal of the Korean Cancer Association(대한암학회지) |
1995 | Perioperative blood transfusions and prognosis in patients with curatively resected locally advanced gatric cancer | ONCOLOGY |
1994 | Changing trends in histologic types of lung cancer during the last decade(1981-1990) in Korean Hospital-based study | LUNG CANCER |
1993 | 위암환자에서 EAP 화학요법으로 유발된 백혈구 감소증에 대한 Neutrogin(rhG-CSF)의 임상효과 | Korean Journal of Biological Response Modifiers(한국 BRM학회지) |